|
⚲
|
| Keyboard |
| Steelhead Capital Management LLC
✚
|
|
|---|---|
| CRD # | 173440 |
| SEC # | 801-117461 |
| CIK # | 0001813887 |
| AUM | 202.5 M (2026-03-30) |
| Employees | 6 (67% Investors, 0% Brokers) |
| Phone | 817-984-9197 |
| Address | 1751 River Run Fort Worth, TX 76107 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Actuate Therapeutics Inc | 27.5 | ||
| Rexahn Pharmaceuticals Inc | 16.8 | ||
| Cognition Therapeutics Inc | 4.6 | ||
| Aileron Therapeutics Inc | 2.6 | ||
| Lantern Pharma Inc | 1.2 | ||
| In8Bio Inc | 0.2 | ||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | BIOS Actuate Co-Invest III LP | [2023-03-30] | 3.2 M | 3.6 M |
| Filed 2022-12-06 (D) · Exemption 506(b) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | BIOS Sirpant Co-Invest I LP | [2022-03-29] | 5.5 M | 5.4 M |
| Offered $10,000,000 · Filed 2021-11-05 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $10,000 · Remaining $4,530,000 · Duration One year or less · Commission $15,900 · Revenue Decline to Disclose | ||||
| VC | BIOS Sirpant Co-Invest I QP LP | [2022-03-29] | 5.5 M | 5.4 M |
| Offered $10,000,000 · Filed 2021-11-05 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000 · Remaining $4,533,700 · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | BIOS Actuate Co-Invest II LP | [2021-03-31] | 12.8 M | |
| Offered $30,000,000 · Filed 2020-09-25 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining $30,000,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | BIOS ONL Co-Invest I LP | [2021-03-31] | 12.6 M | |
| Offered $10,000,000 · Filed 2020-09-25 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining $10,000,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | BIOS Fund III LP | [2020-03-25] | 48.0 M | 12.0 M |
| Offered $100,000,000 · Filed 2020-07-22 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $52,032,000 · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | BIOS Fund III NT LP | [2020-03-25] | 3.9 M | 13.5 M |
| Offered $100,000,000 · Filed 2020-07-22 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $96,133,000 · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | BIOS Fund III QP LP | [2020-03-25] | 48.0 M | 81.8 M |
| Offered $100,000,000 · Filed 2020-07-22 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $52,032,000 · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | BIOS Actuate Co-Invest I LP | [2019-09-09] | 1.8 M | |
| Offered $5,000,000 · Filed 2019-03-26 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining $5,000,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | BIOS Azitra Co-Invest I LP | [2019-09-09] | 0.4 M | 0.4 M |
| Offered $3,000,000 · Filed 2019-03-11 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining $2,562,500 · Duration One year or less · Revenue Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 20 | 202.5 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 20 | 202.5 |
| By Discretionary | ||
| Discretionary | 20 | 202.5 |
| Non-Discretionary | 0 | 0.0 |
| Total | 20 | 202.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 202.5 | |
| Total | 20 | 202.5 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Aaron Fletcher | Director, Executive Officer, Promoter | 64 | 3 | |
| Leslie Kreis Jr | Director, Executive Officer, Promoter | 42 | 3 | |
| Cavu Advisors | Director, Promoter | 30 | 3 | |
| Cavu Management | Director, Promoter | 30 | 3 | |
| Steelhead Capital Management | Director, Promoter | 30 | 3 | |
| Bios Capital Management | Director, Promoter | 29 | 3 | |
| Bios Advisors GP | Director, Promoter | 29 | 3 | |
| Bios Capital Management LP | Promoter | 8 | 3 | |
| Bios Advisors GP LLC | Director | 4 | 3 | |
| Bios Equity Partners III | Director | 12 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001813887] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Comparable Firms | State | AUM |
|---|---|---|
|
White Rock Oil & Gas Holdings LLC
✚
|
TX | 205.1 M |
|
Extant Capital LLC
✚
|
NY | 204.3 M |
|
Rayliant Investment Research
✚
|
CA | 203.5 M |
|
Harmont Fixed Income LLC
✚
|
202.8 M | |
|
Level One Global Advisors LLC
✚
|
FL | 201.5 M |
|
AI Alpha LLC
✚
|
MI | 200.0 M |
|
Gladowsky Capital Management Corp
✚
|
NY | 197.8 M |
|
Calvert Impact Advisory Services LLC
✚
|
MD | 197.8 M |
|
Reciprocal Venture Management LLC
✚
|
NY | 196.9 M |
|
Frugal Financial Retirement Plan Services LLC
✚
|
AL | 194.9 M |